CN Patent

CN119385943A — 盐酸去氧肾上腺素注射液及其制剂工艺

Assigned to Chengdu Easton Biopharmaceuticals Co Ltd · Expires 2025-02-07 · 1y expired

What this patent protects

本发明涉及制药领域，尤其是涉及化学药品注射剂。本发明具体公开了一种盐酸去氧肾上腺素注射液及其制剂工艺，其处方由盐酸去氧肾上腺素、氯化钠、焦亚硫酸钠、抗氧剂2、柠檬酸钠二水合物、柠檬酸一水合物和注射用水组成，其中抗氧剂2为硫化甘油时，再加上经过优化后的制备工艺制备出的盐酸去氧肾上腺素注射液，具有成分简单、对人体的危害小、杂质含量低、质量稳定且安全的特点。

USPTO Abstract

本发明涉及制药领域，尤其是涉及化学药品注射剂。本发明具体公开了一种盐酸去氧肾上腺素注射液及其制剂工艺，其处方由盐酸去氧肾上腺素、氯化钠、焦亚硫酸钠、抗氧剂2、柠檬酸钠二水合物、柠檬酸一水合物和注射用水组成，其中抗氧剂2为硫化甘油时，再加上经过优化后的制备工艺制备出的盐酸去氧肾上腺素注射液，具有成分简单、对人体的危害小、杂质含量低、质量稳定且安全的特点。

Drugs covered by this patent

Patent Metadata

Patent number
CN119385943A
Jurisdiction
CN
Classification
—
Expires
2025-02-07
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Easton Biopharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.